Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 8, 2016 (10 years ago)

Ninjacof (chlophedianol HCl and pyrilamine maleate)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Cause type: Microbial contamination

Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection. All microbial contamination recalls.

What was recalled

Ninjacof (chlophedianol HCl and pyrilamine maleate) Liquid, 12.5 mg/12.5 mg in each 5 mL, 16 fl oz (473 mL) bottle, Manufactured for: Centurion Labs, LLC, Birmingham, AL 35243, NDC 23359-032-16.

Affected NDC 23359-0032-16

Compare with the code on your package — it is the most precise check available.

Drug: Pyrilamine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Ninjacof
chlophedianol hcl and pyrilamine maleate
NDC 23359-0032
CHLOPHEDIANOL HYDROCHLORIDE 12.5 mg/5mL; PYRILAMINE MALEATE 12.5 mg/5mL Solution
Oral
Centurion Labs, LLC OTC
Recalling firm
Pharmatech LLC
NDC code
23359-032-16
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1521-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Pyrilamine recalls

See all
Class II · Moderate risk

Ninjacof-A

Microbial contamination of Non-sterile Products; potential B. cepacia contamination

Terminated Microbial contamination Centurion Labs, LLC NDC 23359-033-16 D-1141-2017
Class II · Moderate risk

Ninjacof-A

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Terminated Microbial contamination Pharmatech LLC NDC 23359-033-16 D-1522-2016
Class III · Low risk

Midol Complete

Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.

Terminated Labeling / mix-up Bayer Healthcare, LLC NDC 0280-8005-16 D-1424-2012
Class III · Low risk

Midol Complete

Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.

Terminated Labeling / mix-up Bayer Healthcare, LLC NDC 0280-8015-24 D-1423-2012

Other recalls by Pharmatech LLC

All 2016 recalls
Class II · Moderate risk

Rugby Aller-chlor

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination Pharmatech LLC D-0227-2018
Class II · Moderate risk

Rugby Diocto Syrup

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination Pharmatech LLC D-0225-2018
Class II · Moderate risk

Rugby Diocto Liquid

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination Pharmatech LLC D-0224-2018